GlassScriptPhysician profile
Jessica A Snyder
NPI 1598087538
$2,384.32
in general payments reported to CMS, 2019-2025
13 companies · $820 in 2025
The $820 reported for 2025 was more than what 87% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $283 · 2022: $412 · 2023: $392 · 2024: $477 · 2025: $820.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,689.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,689.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $741.67 | 2021-2025 | Lifevest |
| Medtronic, INC. | $450.59 | 2021-2025 | Corevalve Evolut R |
| Abiomed | $346.01 | 2023-2025 | Impella |
| Edwards Lifesciences Corporation | $310.10 | 2021-2025 | Sapien 3 Ultra Resilia, Hemosphere, Evoque |
| Saphena Medical, INC. | $147.60 | 2022 | |
| Atricure, INC. | $104.17 | 2024 | |
| Abbott Laboratories | $85.22 | 2023-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Navitor |
| E.R. Squibb & Sons, L.L.C. | $71.95 | 2022-2024 | Eliquis |
| Livanova USA, INC. | $36.84 | 2021 | |
| Smith+Nephew, INC. | $36.24 | 2023-2025 | Pico, Pico 7 |
| Janssen Pharmaceuticals, INC | $18.80 | 2024 | Xarelto |
| Impulse Dynamics (USA) INC. | $18.73 | 2024 | Optimizer |
| Genentech USA, INC. | $16.40 | 2024 | Venclexta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Snyder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.